Recommended Products
form
solution
Quality Level
IVD
for in vitro diagnostic use
concentration
2.4 g/L
application(s)
hematology
histology
shipped in
dry ice
storage temp.
−20°C
Application
Intended for use in the Sigma α-Butyrate Esterase kit, procedure 181B
Packaging
2.4g/L alpha-naphthyl butyrate in methanol solution with stabilizers
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Flam. Liq. 3 - STOT SE 1
Target Organs
Eyes,Central nervous system
WGK
WGK 3
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 24(9), 1221-1228 (2011-05-17)
Folate receptor alpha (FRα), encoded by folate receptor 1 (adult) gene, has emerged as a cancer biomarker and potential therapeutic target. In addition, its expression in tumors may offer prognostic information. The aim of this study was to assess the
Cell proliferation, 40(5), 780-794 (2007-09-20)
Cell immortalization is considered to be a prerequisite status for carcinogenesis. Normal human ovarian surface epithelial (OSE) cells, which are thought to be the origin of most of human ovarian carcinomas, have a very limited lifespan in culture. Establishment of
Oncogene, 19(6), 827-830 (2000-03-04)
We have previously demonstrated that the human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein represses the trans-activation function of p53 tumor suppressor protein. Recently, several proteins with sequence homology to p53 have been identified. In this study, we demonstrated
Revista do Colegio Brasileiro de Cirurgioes, 36(1), 24-34 (2010-01-16)
To correlate the expression of p53 protein and VEGF with the prognosis of patients submitted to curative resection to treat esophageal adenocarcinoma. Forty-six patients with esophageal adenocarcinoma, submitted to curative resection, were studied. The expressions of p53 protein and VEGF
Head & neck oncology, 2, 5-5 (2010-02-24)
Head and neck squamous cell carcinoma (HNSCC) is an aggressive and lethal malignancy. Publically available cell lines are mostly of lingual origin, or have not been carefully characterized. Detailed characterization of novel HNSCC cell lines is needed in order to
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service